Literature DB >> 8455580

Molecular characteristics in Japanese patients with lipidosis: novel mutations in metachromatic leukodystrophy and Gaucher disease.

Y Eto1, H Kawame, Y Hasegawa, T Ohashi, H Ida, T Tokoro.   

Abstract

The characterization of mutations in Japanese patients with lipidosis, particularly in metachromatic leukodystrophy (MLD) and Gaucher disease has been studied in detail. Metachromatic leukodystrophy is characterized by an accumulation of sulfatide in nervous tissues and kidney due to a deficiency of arylsulfatase A (ASA). We analyzed the presence of three known mutant arylsulfatase A alleles in Japanese patients with MLD. Among 10 patients of Japanese patients with MLD, we found that allele 445A mutation has moderately high incidence and also homozygosity of this mutation results in the late infantile form. Allele 2381T was not found in Japanese patients. Furthermore, we found novel mutation which is G- to A mutation at the 1070 nucleotide of the ASA gene (designated 1070 A) in Japanese patients with juvenile onset. This mutation results in a amino acid substitution of Gly245 by Arg and found in heterozygote form. Our studies of molecular analysis in 10 Japanese patients with MLD indicate that Japanese MLD patients have unique characteristics of ASA mutations compared with those of Caucasian patients. On the other hand, Gaucher disease is the most prevalent sphingolipidosis, characterized by an accumulation of glucocerebroside in macrophage derived cells due to a deficiency of lysosomal hydrolase glucocerebrosidase. To study the molecular basis of Gaucher disease in Japanese patients, we analyzed the presence of the two known mutations (6433C and 3548A) in the glucocerebrosidase gene of 15 patients with Gaucher disease. We found that the 6433C and 3548A mutations occur in all subtypes of Japanese patients with Gaucher disease.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8455580     DOI: 10.1007/bf00926869

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  22 in total

1.  METABOLISM OF GLUCOCEREBROSIDES. II. EVIDENCE OF AN ENZYMATIC DEFICIENCY IN GAUCHER'S DISEASE.

Authors:  R O BRADY; J N KANFER; D SHAPIRO
Journal:  Biochem Biophys Res Commun       Date:  1965-01-18       Impact factor: 3.575

2.  EVIDENCE FOR THE GENETIC BLOCK IN METACHROMATIC LEUCODYSTROPHY (ML).

Authors:  E MEHL; H JATZKEWITZ
Journal:  Biochem Biophys Res Commun       Date:  1965-05-03       Impact factor: 3.575

3.  Nucleotide sequence of cDNA containing the complete coding sequence for human lysosomal glucocerebrosidase.

Authors:  S Tsuji; P V Choudary; B M Martin; S Winfield; J A Barranger; E I Ginns
Journal:  J Biol Chem       Date:  1986-01-05       Impact factor: 5.157

4.  Molecular cloning and nucleotide sequence of human glucocerebrosidase cDNA.

Authors:  J Sorge; C West; B Westwood; E Beutler
Journal:  Proc Natl Acad Sci U S A       Date:  1985-11       Impact factor: 11.205

5.  Two new arylsulfatase A (ARSA) mutations in a juvenile metachromatic leukodystrophy (MLD) patient.

Authors:  A L Fluharty; C B Fluharty; W Bohne; K von Figura; V Gieselmann
Journal:  Am J Hum Genet       Date:  1991-12       Impact factor: 11.025

6.  An 11-bp deletion in the arylsulfatase A gene of a patient with late infantile metachromatic leukodystrophy.

Authors:  W Bohne; K von Figura; V Gieselmann
Journal:  Hum Genet       Date:  1991-06       Impact factor: 4.132

7.  Mutations in the arylsulfatase A gene of Japanese patients with metachromatic leukodystrophy.

Authors:  Y Hasegawa; H Kawame; Y Eto
Journal:  DNA Cell Biol       Date:  1993 Jul-Aug       Impact factor: 3.311

8.  Complex alleles of the acid beta-glucosidase gene in Gaucher disease.

Authors:  T Latham; G A Grabowski; B D Theophilus; F I Smith
Journal:  Am J Hum Genet       Date:  1990-07       Impact factor: 11.025

9.  Late-onset metachromatic leukodystrophy: molecular pathology in two siblings.

Authors:  J Kappler; K von Figura; V Gieselmann
Journal:  Ann Neurol       Date:  1992-03       Impact factor: 10.422

10.  Non-existence of a tight association between a 444leucine to proline mutation and phenotypes of Gaucher disease: high frequency of a NciI polymorphism in the non-neuronopathic form.

Authors:  M Masuno; S Tomatsu; K Sukegawa; T Orii
Journal:  Hum Genet       Date:  1990-01       Impact factor: 4.132

View more
  3 in total

1.  Alglucerase for Gaucher's disease: dose, costs and benefits.

Authors:  E Beutler; A M Garber
Journal:  Pharmacoeconomics       Date:  1994-06       Impact factor: 4.981

2.  Non-pseudogene-derived complex acid beta-glucosidase mutations causing mild type 1 and severe type 2 gaucher disease.

Authors:  M E Grace; P Ashton-Prolla; G M Pastores; A Soni; R J Desnick
Journal:  J Clin Invest       Date:  1999-03       Impact factor: 14.808

3.  Biochemical and Genetic Analysis of Seven Korean Individuals With Suspected Metachromatic Leukodystrophy.

Authors:  Minje Han; Sun-Hee Jun; Yun-Jin Lee; Baik-Lin Eun; Seung Jun Lee; Moon-Woo Seong; Sung Sup Park; Sang Hoon Song; Hyung-Doo Park; Junghan Song
Journal:  Ann Lab Med       Date:  2015-05-21       Impact factor: 3.464

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.